SBFM Q2 2021 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$52,874+249.1% YoY

Gross Profit

$34,35965.0% margin

Operating Income

-$389,000-735.7% margin

Net Income

-$3M-5445.0% margin

EPS (Diluted)

$-2420.00

QoQ Revenue Growth

+32.0%

Cash Flow

Operating Cash Flow

-$618,852

Free Cash Flow

-$618,852

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2M

Total Liabilities

$3M

Stockholders' Equity

-$872,710

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52,874	$15,145	+249.1%
Gross Profit	$34,359	$9,984	+244.1%
Operating Income	-$389,000	-$128,569	-202.6%
Net Income	-$3M	-$907,444	-217.3%